Pharmaceutical News

RSS

UAB physician calls for better education, legislation to help patients with opioid abuse

The U.S. opioid epidemic has evolved so much in the last four years that current federal policy responses risk diminishing returns in saving human lives, according to a new peer-reviewed perspective by University of Alabama at Birmingham Associate Professor of Preventive medicine Stefan Kertesz, M.D. His perspective was published online in the addiction journal Substance Abuse.

24 Nov 2016

Cancer gene mutations can predict response to less intensive treatment in AML patients

Patients with the most lethal form of acute myeloid leukemia (AML) - based on genetic profiles of their cancers - typically survive for only four to six months after diagnosis, even with aggressive chemotherapy.

23 Nov 2016

New vaccine shows potential to decrease risk of fatal opioid overdose

Scientists at The Scripps Research Institute have developed a vaccine that blocks the pain-numbing effects of the opioid drugs oxycodone and hydrocodone in animal models.

23 Nov 2016

Persavita’s flagship natural eye health product Saffron 2020 receives U.S. patent

Persavita Inc. is pleased to announce the successful issue of the United States patent for its flagship natural eye health product, Saffron 2020.

23 Nov 2016

Clinically-proven pharmacy product effective against causes of Traveller's Diarrhoea

It is not only overseas holidays that can be ruined by the dreaded Traveller's Diarrhoea.

23 Nov 2016

Dietary supplement extracted from Amaranthus can increase plasma nitrate, study shows

A new, clinical study confirms that dietary supplementation of nitrate from a natural extract of Amaranthus species nicknamed "red spinach," results in a significant increase in plasma nitrite that ultimately enhances nitric oxide.

23 Nov 2016

ADVANCECAT enables development of advanced therapies to benefit Catalan health system

Enabling the arrival of advanced therapies from pre-clinical stages to industrial production and clinical application: this is the objective of ADVANCECAT project, led by the University of Barcelona and Ferrer, and build up by eighteen entities of the health field in which there are two universities, twelve biomedical research institutes or private foundations, and four companies.

23 Nov 2016

Study reveals new insights into drug-caused deaths among health care professionals

An Australian-first study conducted by Monash University has found that from 2003-2013 nearly five deaths per 1000 employed Australian health care professionals were caused by drugs, with a significant association between specific professions and drug type.

23 Nov 2016

ADD Program receives $19.5 million NIH contract to test drugs for treating epilepsy

The University of Utah College of Pharmacy's Anticonvulsant Drug Development Program has been awarded a five-year $19.5 million contract renewal with the National Institutes of Health to test drugs to treat epilepsy, and the major focus of the project is to address needs that affect millions of people worldwide -identify novel investigational compounds to prevent the development of epilepsy or to treat refractory, or drug-resistant, epilepsy.

23 Nov 2016

IQWiG finds colorectal cancer drug combination has added benefit only for some patients

The fixed combination of trifluridine/tipiracil has been approved since April 2016 for the treatment of metastatic colorectal cancer.

23 Nov 2016

Melanoma drug offers considerable added benefit for patients with advanced NSCLC

Pembrolizumab was initially introduced for the treatment of melanoma. Since July 2016, the monoclonal antibody has also been available for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) in adults whose tumours express the T-cell receptor ligand PD-L1 and who have received a prior chemotherapy regimen.

22 Nov 2016

New combinatination therapy shows promise in treating patients with traumatic brain injury

A combination of the stimulant drug methylphenidate with a process known as cognitive-behavioral rehabilitation is a promising option to help people who suffer from persistent cognitive problems following traumatic brain injury, researchers at Indiana University School of Medicine have reported.

22 Nov 2016

Pregnant women at risk of infection do not receive flu vaccination, UBC study finds

Health-care professionals are hesitant to administer the flu vaccine to pregnant women, despite the potential life-saving benefits, according to a UBC study.

22 Nov 2016

New antiretroviral treatments show potential to reduce chances of sexual transmission of HIV virus

More than 2 million people got infected by human immunodeficiency virus (HIV) in 2015, being sexual transmission the main channel of infection.

22 Nov 2016

Researchers make significant progress in developing frontline protection against HIV infection

Researchers have made significant progress in the development of a potential vaccine to protect against HIV infection.

22 Nov 2016

Study shows new drug combination effective in treating precancerous skin lesions

A combination of two topical drugs that have been in use for years triggers a robust immune response against precancerous skin lesions, according to a new study. The research, from Washington University School of Medicine in St. Louis and Harvard Medical School, shows that the therapy activates the immune system's T cells, which then attack the abnormal skin cells.

21 Nov 2016

Opioid exposure may impact healing in patients with chronic wounds

$Already available drug accelerates healing process after hip fracture$

Already available drug accelerates healing process after hip fracture

An already available drug can help patients get back on their feet more rapidly after a hip fracture, according to an international study published in the Journal of Bone Joint Surgery.

21 Nov 2016

Pharmaceutical News

UAB physician calls for better education, legislation to help patients with opioid abuse

Cancer gene mutations can predict response to less intensive treatment in AML patients

New vaccine shows potential to decrease risk of fatal opioid overdose

Persavita’s flagship natural eye health product Saffron 2020 receives U.S. patent

Clinically-proven pharmacy product effective against causes of Traveller's Diarrhoea

Dietary supplement extracted from Amaranthus can increase plasma nitrate, study shows

ADVANCECAT enables development of advanced therapies to benefit Catalan health system

Study reveals new insights into drug-caused deaths among health care professionals

ADD Program receives $19.5 million NIH contract to test drugs for treating epilepsy

IQWiG finds colorectal cancer drug combination has added benefit only for some patients

Melanoma drug offers considerable added benefit for patients with advanced NSCLC

New combinatination therapy shows promise in treating patients with traumatic brain injury

Pregnant women at risk of infection do not receive flu vaccination, UBC study finds

New antiretroviral treatments show potential to reduce chances of sexual transmission of HIV virus

Researchers make significant progress in developing frontline protection against HIV infection

Study shows new drug combination effective in treating precancerous skin lesions

Opioid exposure may impact healing in patients with chronic wounds

TSRI scientists offer novel structure-based drug design strategy for better breast cancer treatment

Vitamin D supplementation improves autism symptoms, study shows

Already available drug accelerates healing process after hip fracture

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Latest News